Jubilant DraxImage continues to advance our pipeline of generic and novel diagnostic and therapeutic products, building upon our core competency in the areas of radiopharmaceuticals, lyophilized kits, and advanced technologies. Externally, we continually evaluate opportunities to acquire products or technologies that serve patients while strengthening our strategic position in the industry through partnerships or in-licensing agreements.